Jun
2026
Shanghai New International Expo Center
Visit us
stand W4F58, Biotech

Thousand Oaks Biologics Inc.

About Us

Thousand Oaks Biologics Inc. (TOBio), a premier Integrated CMC Solution Provider, focuses on comprehensive solutions for large - scale, compliant biopharmaceutical production. Its business covers three main segments: Biopharmaceutical CDMO, Cell Culture Medium, and Early - Stage Research Services. Its products and technical services find extensive applications in the production of recombinant proteins, antibody - based drugs, human and veterinary vaccines, and cell therapy products. In CDMO, TOBio offers end - to - end CMC solutions at its Shanghai and Nantong GMP bases, serving diverse biopharmaceuticals. JSBio, under TOBio, excels in serum - free cell culture media, providing R&D, production, and customized services with kiloton - scale capacity across China and South Korea. Ginspire Biologics drives early - stage research, offering molecular design, evaluation, and optimization to boost complex molecule development success. This dedication across its business segments underscores TOBio’ s unwavering commitment to making biologics more accessible and affordable for humanity.

  • Country/Region:
    China
  • On CPHI since:
    2024
  • Certificates:
    4
  • Employees:
    500 - 999
Company types
Biopharmaceutical company
CMO/CDMO
Contract Service
Drug delivery device Supplier/Manufacturer
Pharmaceutical company
Primary activities
Analytical Services
Biopharmaceutical
Contract Manufacturer
Intermediates Manufacturer
Pharmaceutical Company (innovator finished products)
Supply Chain
Technology
Contact info
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand W4F58, Biotech

Products Featured at CPHI & PMEC China 2026

  • Cell Culture Media

    Product Cell Culture Media

    JSBio, a prominent brand in Asia, is a leading provider of serum-free cell culture media. Our comprehensive product portfolio covers a wide spectrum of cell lines, with a strong focus on mainstream ones like CHO, 293, insect cells, and BHK .These media are extensively applied across core biopharmaceutical ...
  • CDMO Services

    Product CDMO Services

    Thousand Oaks Biopharmaceutical (TOBio), as a CDMO specializing in the large molecule sector, offers an integrated suite of CMC solutions from candidate molecules through clinical and commercial manufacturing. Operating with the philosophy of an "innovator's drug development perspective," the core technica...
  • Early-stage Drug Discovery

    Product Early-stage Drug Discovery

    An early research services subsidiary of Thousand Oaks Biologics offers molecular design and optimization, linker-payload and antibody screening, pharmacological efficacy and drug evaluation, and other services. Collaborates with clients on demand to develop differentiated innovative molecules and licenses...

Thousand Oaks Biologics Inc Resources (1)